.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Constellation Cannabis concentrated its mix around Concentrates at 40.05% share with year-over-year growth of 49.59% and month-over-month growth of 13.03%, while Edible contracted to 23.75% share with a -23.75% YoY change and -4.68% MoM. Beverage held 14.65% share with -5.99% YoY and -1.49% MoM, and Pre-Roll slid to 10.11% share with -5.99% YoY and a sharp -31.17% MoM. Vapor Pens fell to 5.61% share with -47.56% YoY and -9.34% MoM, and Flower compressed to 3.20% share with -60.42% YoY and -27.93% MoM; Capsules remain small at 2.63% share but posted 71.48% YoY and -2.21% MoM. With brand sales down -4.39% YoY and average price up 0.62%, the pattern implies a deliberate pivot toward higher-priced inhalables led by Concentrates, using growth in a single anchor category to offset double‑digit declines in Pre-Roll and Flower.
The category shifts imply a specialization strategy anchored in Washington Concentrates, where a #3 rank suggests defensible visibility even as adjacent inhalable formats retrench by -31.17% MoM in Pre-Roll and -9.34% MoM in Vapor Pens. The divergence between 49.59% YoY growth in Concentrates and -60.42% YoY in Flower, paired with a 13.03% MoM gain in Concentrates versus -1.49% MoM in Beverage, points to resource and shelf focus away from commoditized categories toward potency- and format-driven niches; the implication is that maintaining or improving the #3 Concentrates position should be prioritized to stabilize overall sales while selectively pruning underperforming Flower and Vapor Pens exposure.
Competitive Landscape
Constellation Cannabis is ranked #3 in WA Concentrates in May 2026, improving 5 positions from #8 in May 2025, while holding steady at #3 since March 2026; by comparison, Ooowee stayed at #1 but posted a -8.39% year-over-year sales change, and Dabstract moved from #6 to #4 with 22.13% year-over-year growth. The brand’s peak rank is #3 reached in May 2026, and it is currently 1 position behind Delectable Dabs at #2, whose sales declined -9.93% year over year, while Oleum Extracts (Oleum Labs) slid from #4 to #5 with a -4.46% year-over-year change. This rank trajectory implies Constellation Cannabis has broken into the top tier and can pressure the #2 spot as incumbents at #1 and #2 post negative year-over-year trends, while the main upward threat is the #4 brand accelerating from #6.
Notable Products
Gravity - CBG/CBD/THC 1:1:1 Watermelon Hash Rosin Gummies 10-Pack (100mg CBG ,100mg CBD, 100mg THC) posted a -13.2% month-over-month decline in May 2026 while holding rank 3, and Moonshot - Grape Nano Emulsified Hash Rosin Beverage (100mg THC, 1.7oz) slipped -11.3% at rank 8. In contrast, Moonshot - Peach Mango Nano Emulsified Hash Rosin Beverage (100mg THC, 1.7oz) inched up +1.8% at rank 4 while the flagship Moonshot - Blue Raspberry Nano Emulsified Hash Rosin Beverage (100mg THC, 1.7oz) dipped -5.2% yet stayed at rank 1. The pattern implies demand concentration in top-ranked beverages even as a leading edible contracts, pointing to a portfolio leaning on Moonshot velocity more than Gravity recovery.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
